Open Access. Powered by Scholars. Published by Universities.®

Biomedical Engineering and Bioengineering Commons™

Open Access. Powered by Scholars. Published by Universities.®

2012

Discipline
Institution
Keyword
Publication
Publication Type
File Type

Articles 241 - 270 of 535

Full-Text Articles in Biomedical Engineering and Bioengineering

Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg May 2012

Bacterial Expression Of A Vlp Sub-Unit For Rapid And Cheap Influenza Vaccination, Anton Middelberg

Vaccine Technology IV

No abstract provided.


Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay May 2012

Developing A Suite Of Analytics To Support Process Development For The Manufacture Of Polysaccharides, Aaron Noyes, Ranga Godavarti, Nigel Titchener-Hooker, Jonathan Coffman, Tarit Mukhopadhyay

Vaccine Technology IV

No abstract provided.


Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai May 2012

Cervical Cancer Immunotherapy: Induction Of Hpv Specific Ctls In Human Volunteers After Vgx-3100 Immunization, Niranjan Sardesai

Vaccine Technology IV

No abstract provided.


A Protein-Free Process And Product Protection System, Stephen Ward May 2012

A Protein-Free Process And Product Protection System, Stephen Ward

Vaccine Technology IV

No abstract provided.


Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity May 2012

Functional Genomics As A Tool To Define A Molecular Signature Of Effective Vaccination Against Foot And Mouth Disease Virus, Jose Chabalgoity

Vaccine Technology IV

No abstract provided.


Oncolytic Viruses As Cancer Therapies, Stephen Rusell May 2012

Oncolytic Viruses As Cancer Therapies, Stephen Rusell

Vaccine Technology IV

No abstract provided.


Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca May 2012

Chimpanzee Ad Vector Technology Platform For Prophylactic And Therapeutic Genetic Vaccine Applications, Stefano Colloca

Vaccine Technology IV

No abstract provided.


Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke May 2012

Challenges In Optimizing Formulations For Multi- Antigen Vaccines, Lakshmi Khandke

Vaccine Technology IV

No abstract provided.


A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters May 2012

A New Successful Vaccine Against Babesiosis: Any Use For Malaria?, Thep Schetters

Vaccine Technology IV

No abstract provided.


The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love May 2012

The Cmc Challenges In Developing An Oncolytic Immunotherapy, Colin Love

Vaccine Technology IV

No abstract provided.


High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan May 2012

High Throughput Formulation Design For A Stable Lyophilized Virus-Like Particle Vaccine Against Group A Streptococcu, Yap Chuan

Vaccine Technology IV

No abstract provided.


Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn May 2012

Process Development For A Peptide Conjugated Qbetavirus Like Particle (Vlp) Vaccine, Jennifer Thorn

Vaccine Technology IV

No abstract provided.


Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz May 2012

Formulation And Stability Of A Chikungunya Virus-Like Particle (Chikv Vlp) Based Vaccine, Rhicard Schwartz

Vaccine Technology IV

No abstract provided.


Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird May 2012

Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird

Vaccine Technology IV

No abstract provided.


Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid May 2012

Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid

Vaccine Technology IV

No abstract provided.


Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm May 2012

Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm

USF Tampa Graduate Theses and Dissertations

Stenosis is one of the most common causes for spinal surgery. Laminectomy decompression and fusion are surgical procedures prescribed for this condition. The intention of this work was to investigate the effects of a laminectomy decompression, followed by fusion, on a lumbar functional spinal unit (FSU) through in vitro dynamic (±8Nm at 0.125Hz) and quasi-static (±7.5Nm at 0.1Hz) biomechanical tests, for flexion, extension, bending and rotation motions.

Six FSUs where disarticulated from four human cadaveric lumbar spines (63 ± 12 years) and were tested under the following sequence: (1) intact, (2) laminectomy decompression, and (3) Pedicle Screw System (PSS), using …


Conference Program, Engineering Conferences International May 2012

Conference Program, Engineering Conferences International

Vaccine Technology IV

No abstract provided.


Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell May 2012

Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell

Vaccine Technology IV

No abstract provided.


Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson May 2012

Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson

Vaccine Technology IV

No abstract provided.


Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto May 2012

Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto

Vaccine Technology IV

No abstract provided.


Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi May 2012

Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi

Vaccine Technology IV

No abstract provided.


Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras May 2012

Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras

Vaccine Technology IV

No abstract provided.


Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo May 2012

Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo

Vaccine Technology IV

No abstract provided.


The Role Of Public-Private Partnerships In Advancing Vaccine Technologies And Improving Vaccine Effectiveness And Delivery For Developing Countries, Ray Cummings May 2012

The Role Of Public-Private Partnerships In Advancing Vaccine Technologies And Improving Vaccine Effectiveness And Delivery For Developing Countries, Ray Cummings

Vaccine Technology IV

No abstract provided.


Challenges In Batch Production Of Malaria Vaccines, Nicolas Havelange May 2012

Challenges In Batch Production Of Malaria Vaccines, Nicolas Havelange

Vaccine Technology IV

No abstract provided.


Establishing Human Vaccine Manufacturing In Southern Africa, Morena Makhoana May 2012

Establishing Human Vaccine Manufacturing In Southern Africa, Morena Makhoana

Vaccine Technology IV

No abstract provided.


Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio, Takashi Kishimoto May 2012

Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio, Takashi Kishimoto

Vaccine Technology IV

No abstract provided.


Recombinant Vlp Based Human Vaccines For Emerging Markets, Qinjian Zhao May 2012

Recombinant Vlp Based Human Vaccines For Emerging Markets, Qinjian Zhao

Vaccine Technology IV

No abstract provided.


111 Years Producing Immunobiologicals: New Challenges, Jorge Kalil May 2012

111 Years Producing Immunobiologicals: New Challenges, Jorge Kalil

Vaccine Technology IV

No abstract provided.


Development Of A Vaccine Against Clostridium Difficile Infection (Cdi): Design, Purification, And Biological Activities Of The Recombinant Toxin 1 Antigens, Jerzy Karczewski May 2012

Development Of A Vaccine Against Clostridium Difficile Infection (Cdi): Design, Purification, And Biological Activities Of The Recombinant Toxin 1 Antigens, Jerzy Karczewski

Vaccine Technology IV

No abstract provided.